🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesis

Journal of Thoracic and Cardiovascular Surgery(2023)10.1016/j.jtcvs.2023.08.017Source: DataRank Database

Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesis is a research paper published in Journal of Thoracic and Cardiovascular Surgery (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 2.25)OA: bronzeTopics (28)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Sharif A. Sabe ORCID,Hang Xing ORCID,Cynthia Xu ORCID,Mohamed Sabra ORCID,Dwight D. Harris ORCID

Live enrichment

PubMed:37604273 PMC:PMC10840801 OpenAlex:https://openalex.org/W4386012954

National Institute of General Medical Sciences

Grant: 1R01HL127072-01A1

National Institute of General Medical Sciences

Grant: F32HL160063

National Institute of General Medical Sciences

Grant: R01HL128831

National Institute of General Medical Sciences

Grant: R01HL136347-04S1

National Institute of General Medical Sciences

Grant: R01HL46716

National Institute of General Medical Sciences

Grant: R01HL133624

National Institute of General Medical Sciences

Grant: T32GM065085-18

National Institute of General Medical Sciences

Grant: T32HL160517

NHLBI NIH HHS

Grant: R01 HL127072

NIGMS NIH HHS

Grant: T32 GM065085

NHLBI NIH HHS

Grant: R25 HL088992

NHLBI NIH HHS

Grant: R56 HL133624

NHLBI NIH HHS

Grant: R01 HL046716

NHLBI NIH HHS

Grant: R01 HL136347

National Institutes of Health

FWCI

2.25

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jtcvs.org/article/S0022522323007298/pdf

publisherhttp://www.jtcvs.org/article/S0022522323007298/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022522323007298?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022522323007298?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtcvs.2023.08.017

Fields of Study

Diabetes Treatment and ManagementCardiovascular Function and Risk FactorsAngiogenesis and VEGF in Cancer

MeSH Terms

CanagliflozinSodium-Glucose Transporter 2 InhibitorsAnimalsMyocardiumSwineVasodilationMyocardial IschemiaVascular Endothelial Growth Factor AEndostatinsRats

Keywords

Internal medicineEndocrinologyMedicineVasodilationAngiogenesisVascular endothelial growth factorIschemiaCanagliflozinPerfusionCardiologyDiabetes mellitusType 2 diabetesMyocardial perfusionChronic Myocardial IschemiaMicrovascular Reactivity

Sustainable Development Goals

SDG 0: Good health and well-being